Jubilant Pharmova Ltd.
•₹ 880.351.07%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Radiopharma: 44.3% • Contract Development & Manufacturing Organisation Sterile Injectables: 21.7% • Contract Research & Development Services: 15.2% • Allergy Immunotherapy: 9.5% • Generics: 9.3%
PROS
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.50x)
- Company has a consistent dividend-paying track record
- Company generates healthy free cash flow
- Company maintains a comfortable, low leverage position
CONS
- Recent results are weak - TTM profit is down 30.8% versus prior year
- Company has a low return on capital employed of 9.2%
- Company has a low return on equity of 7.2% over last 3 years
- Promoter holding has decreased over last 2 years: -3.0pp
- Company has delivered a poor profit growth of -7.1% over past five years
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | JUBLPHARMA | 868.60 | 39.29 | 13835.16 | 0.58 | 56.40 | -44.98 | 2229.40 | 18.65 | 8.69 | 11.12 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,566 | 1,667 | 1,665 | 1,746 | 1,720 | 1,742 | 1,814 | 1,916 | 1,879 | 1,958 | 2,116 | 2,272 | 2,229 | |
| 1,417 | 1,438 | 1,459 | 1,487 | 1,480 | 1,463 | 1,534 | 1,583 | 1,611 | 1,625 | 1,833 | 1,951 | 2,163 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 9 | 10 | 36 | 14 | 14 | 22 | 9 | 12 | 12 | 10 | 20 | 24 | 20 |
| Interest | 62 | 66 | 71 | 73 | 71 | 61 | 56 | 53 | 49 | 50 | 56 | 56 | 54 |
| Depreciation | 90 | 97 | 95 | 101 | 91 | 91 | 91 | 95 | 98 | 105 | 121 | 117 | 127 |
| 27 | 89 | 88 | -57 | 500 | 144 | 131 | 206 | 154 | 190 | 94 | 176 | 86 | |
| Tax % | 72.18% | 40.34% | 39.36% | -14.19% | 3.58% | 29.00% | 22.78% | 26.54% | 33.59% | 36.97% | 40.21% | 32.22% | 34.72% |
| Net Profit | 0 | 0 | 0 | 0 | 482 | 102 | 101 | 151 | 102 | 120 | 56 | 119 | 56 |
| 0 | 4 | 4 | -4 | 30 | 6 | 6 | 10 | 6 | 8 | 4 | 8 | 0 | |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 1,566
- 1,417
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 62
- Depreciation
- 90
- 27
- Tax %
- 72.18%
- Net Profit
- 0
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 1,667
- 1,438
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 66
- Depreciation
- 97
- 89
- Tax %
- 40.34%
- Net Profit
- 0
- 4
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 1,665
- 1,459
- Operating Profit
- —
- OPM %
- —
- Other Income
- 36
- Interest
- 71
- Depreciation
- 95
- 88
- Tax %
- 39.36%
- Net Profit
- 0
- 4
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 1,746
- 1,487
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 73
- Depreciation
- 101
- -57
- Tax %
- -14.19%
- Net Profit
- 0
- -4
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 1,720
- 1,480
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 71
- Depreciation
- 91
- 500
- Tax %
- 3.58%
- Net Profit
- 482
- 30
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 1,742
- 1,463
- Operating Profit
- —
- OPM %
- —
- Other Income
- 22
- Interest
- 61
- Depreciation
- 91
- 144
- Tax %
- 29.00%
- Net Profit
- 102
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 1,814
- 1,534
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 56
- Depreciation
- 91
- 131
- Tax %
- 22.78%
- Net Profit
- 101
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 1,916
- 1,583
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 53
- Depreciation
- 95
- 206
- Tax %
- 26.54%
- Net Profit
- 151
- 10
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 1,879
- 1,611
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 49
- Depreciation
- 98
- 154
- Tax %
- 33.59%
- Net Profit
- 102
- 6
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 1,958
- 1,625
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 50
- Depreciation
- 105
- 190
- Tax %
- 36.97%
- Net Profit
- 120
- 8
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 2,116
- 1,833
- Operating Profit
- —
- OPM %
- —
- Other Income
- 20
- Interest
- 56
- Depreciation
- 121
- 94
- Tax %
- 40.21%
- Net Profit
- 56
- 4
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 2,272
- 1,951
- Operating Profit
- —
- OPM %
- —
- Other Income
- 24
- Interest
- 56
- Depreciation
- 117
- 176
- Tax %
- 32.22%
- Net Profit
- 119
- 8
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 2,229
- 2,163
- Operating Profit
- —
- OPM %
- —
- Other Income
- 20
- Interest
- 54
- Depreciation
- 127
- 86
- Tax %
- 34.72%
- Net Profit
- 56
- 0
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5,861 | 7,518 | 9,111 | 5,976 | 6,099 | 6,130 | 6,282 | 6,703 | 7,234 | 8,280 | 8,576 | |
| 4,516 | 5,999 | 7,372 | 4,428 | 4,702 | 4,974 | 5,506 | 5,802 | 6,061 | 7,020 | 7,572 | |
| Operating Profit | 1,370 | 1,558 | 1,775 | 1,585 | 1,414 | 1,168 | 814 | 970 | 1,230 | 1,326 | — |
| OPM % | 23 | 21 | 19 | 27 | 23 | 19 | 13 | 14 | 17 | 16 | — |
| Other Income | 25 | 40 | 36 | 37 | 18 | 11 | 38 | 69 | 57 | 66 | 74 |
| Interest | 341 | 284 | 220 | 200 | 184 | 145 | 188 | 272 | 240 | 212 | 217 |
| Depreciation | 291 | 415 | 371 | 340 | 349 | 382 | 554 | 382 | 369 | 440 | 470 |
| 738 | 859 | 904 | 1,013 | 871 | 630 | 28 | 170 | 981 | 614 | 546 | |
| Tax % | 22 | 26 | 36 | 33 | 34 | 34 | 333 | 57 | 15 | 35 | 36 |
| Net Profit | 575 | 634 | 577 | 678 | 574 | 413 | -65 | 73 | 836 | 398 | 352 |
| EPS | 37 | 41 | 37 | 56 | 52 | 26 | -4 | 5 | 53 | 25 | — |
| Dividend Payout % | 8 | 7 | 12 | 9 | 10 | 19 | -130 | 102 | 9 | 20 | — |
| Minority Interest | 1 | 8 | -3 | 0 | 0 | 1 | 4 | 4 | 3 | 1 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Adjusted EPS | 37 | 41 | 36 | 56 | 53 | 26 | -4 | 5 | 53 | 25 | — |
| Minority Interest | 1 | 8 | -3 | 0 | 0 | 1 | 4 | 4 | 3 | 1 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Adjusted EPS | 37 | 41 | 36 | 56 | 53 | 26 | -4 | 5 | 53 | 25 | — |
Mar 2017
- 5,861
- 4,516
- Operating Profit
- 1,370
- OPM %
- 23
- Other Income
- 25
- Interest
- 341
- Depreciation
- 291
- 738
- Tax %
- 22
- Net Profit
- 575
- EPS
- 37
- Dividend Payout %
- 8
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 37
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 37
Mar 2018
- 7,518
- 5,999
- Operating Profit
- 1,558
- OPM %
- 21
- Other Income
- 40
- Interest
- 284
- Depreciation
- 415
- 859
- Tax %
- 26
- Net Profit
- 634
- EPS
- 41
- Dividend Payout %
- 7
- Minority Interest
- 8
- Share of Associates
- 0
- Adjusted EPS
- 41
- Minority Interest
- 8
- Share of Associates
- 0
- Adjusted EPS
- 41
Mar 2019
- 9,111
- 7,372
- Operating Profit
- 1,775
- OPM %
- 19
- Other Income
- 36
- Interest
- 220
- Depreciation
- 371
- 904
- Tax %
- 36
- Net Profit
- 577
- EPS
- 37
- Dividend Payout %
- 12
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 36
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 36
Mar 2020
- 5,976
- 4,428
- Operating Profit
- 1,585
- OPM %
- 27
- Other Income
- 37
- Interest
- 200
- Depreciation
- 340
- 1,013
- Tax %
- 33
- Net Profit
- 678
- EPS
- 56
- Dividend Payout %
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 56
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 56
Mar 2021
- 6,099
- 4,702
- Operating Profit
- 1,414
- OPM %
- 23
- Other Income
- 18
- Interest
- 184
- Depreciation
- 349
- 871
- Tax %
- 34
- Net Profit
- 574
- EPS
- 52
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 53
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 53
Mar 2022
- 6,130
- 4,974
- Operating Profit
- 1,168
- OPM %
- 19
- Other Income
- 11
- Interest
- 145
- Depreciation
- 382
- 630
- Tax %
- 34
- Net Profit
- 413
- EPS
- 26
- Dividend Payout %
- 19
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 26
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 26
Mar 2023
- 6,282
- 5,506
- Operating Profit
- 814
- OPM %
- 13
- Other Income
- 38
- Interest
- 188
- Depreciation
- 554
- 28
- Tax %
- 333
- Net Profit
- -65
- EPS
- -4
- Dividend Payout %
- -130
- Minority Interest
- 4
- Share of Associates
- 0
- Adjusted EPS
- -4
- Minority Interest
- 4
- Share of Associates
- 0
- Adjusted EPS
- -4
Mar 2024
- 6,703
- 5,802
- Operating Profit
- 970
- OPM %
- 14
- Other Income
- 69
- Interest
- 272
- Depreciation
- 382
- 170
- Tax %
- 57
- Net Profit
- 73
- EPS
- 5
- Dividend Payout %
- 102
- Minority Interest
- 4
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 4
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2025
- 7,234
- 6,061
- Operating Profit
- 1,230
- OPM %
- 17
- Other Income
- 57
- Interest
- 240
- Depreciation
- 369
- 981
- Tax %
- 15
- Net Profit
- 836
- EPS
- 53
- Dividend Payout %
- 9
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- 53
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- 53
Mar 2026
- 8,280
- 7,020
- Operating Profit
- 1,326
- OPM %
- 16
- Other Income
- 66
- Interest
- 212
- Depreciation
- 440
- 614
- Tax %
- 35
- Net Profit
- 398
- EPS
- 25
- Dividend Payout %
- 20
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 25
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- 25
TTM
- 8,576
- 7,572
- Operating Profit
- —
- OPM %
- —
- Other Income
- 74
- Interest
- 217
- Depreciation
- 470
- 546
- Tax %
- 36
- Net Profit
- 352
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 4%
- 5 Years:
- 6%
- 3 Years:
- 10%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 0%
- 5 Years:
- -14%
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 6%
- 5 Years:
- 7%
- 3 Years:
- 25%
- 1 Year:
- -20%
RETURN ON EQUITY
- 10 Years:
- 10%
- 5 Years:
- 6%
- 3 Years:
- 7%
- Last Year:
- 6%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| 3,420 | 4,071 | 4,793 | 5,588 | 4,725 | 5,299 | 5,377 | 5,404 | 6,224 | 7,058 | |
| 540 | 421 | 598 | 889 | 20 | 463 | 258 | 196 | 219 | 162 | |
| Trade Payables | 749 | 1,136 | 1,020 | 1,090 | 520 | 568 | 821 | 856 | 1,005 | 1,234 |
| 4,173 | 3,814 | 4,892 | 4,728 | 3,482 | 3,484 | 4,457 | 4,844 | 5,035 | 6,795 | |
| Total Liabilities | 8,899 | 9,457 | 11,319 | 12,310 | 8,763 | 9,830 | 10,929 | 11,316 | 12,499 | 15,266 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 5,107 | 5,401 | 5,648 | 6,340 | 4,609 | 4,871 | 5,183 | 5,091 | 5,176 | 6,966 | |
| Capital Work in Progress | 211 | 300 | 492 | 264 | 278 | 292 | 773 | 1,252 | 2,715 | 2,962 |
| 103 | 124 | 115 | 69 | 241 | 239 | 256 | 42 | 44 | 61 | |
| 1,220 | 1,391 | 1,417 | 1,845 | 1,129 | 1,255 | 1,380 | 1,290 | 1,129 | 1,232 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 916 | 892 | 1,070 | |
| Cash & Bank | 460 | 249 | 1,370 | 1,400 | 671 | 984 | 1,014 | 957 | 1,089 | 1,268 |
| 1,799 | 1,993 | 2,276 | 2,392 | 1,835 | 2,189 | 2,321 | 1,768 | 1,456 | 1,708 | |
| Total Assets | 8,899 | 9,457 | 11,319 | 12,310 | 8,763 | 9,830 | 10,929 | 11,316 | 12,499 | 15,266 |
| Total Debt | 4,045 | 3,469 | 4,840 | 4,628 | 2,584 | 2,928 | 3,410 | 3,414 | 2,437 | 3,220 |
| Net Working Capital | 1,264 | 1,185 | 2,495 | 2,419 | 1,904 | 1,918 | 1,990 | 1,743 | 1,345 | 1,570 |
| Contingent Liabilities | 473 | 756 | 595 | 702 | 422 | 420 | 402 | 456 | 368 | 419 |
| Book Value per Share | 220.61 | 262.33 | 301.93 | 351.83 | 297.84 | 333.91 | 339.19 | 343.00 | 394.94 | 447.70 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 4,045 | 3,469 | 4,840 | 4,628 | 2,584 | 2,928 | 3,410 | 3,414 | 2,437 | 3,220 |
| Net Working Capital | 1,264 | 1,185 | 2,495 | 2,419 | 1,904 | 1,918 | 1,990 | 1,743 | 1,345 | 1,570 |
| Contingent Liabilities | 473 | 756 | 595 | 702 | 422 | 420 | 402 | 456 | 368 | 419 |
| Book Value per Share | 220.61 | 262.33 | 301.93 | 351.83 | 297.84 | 333.91 | 339.19 | 343.00 | 394.94 | 447.70 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2017
- Equity Capital
- 16
- 3,420
- 540
- Trade Payables
- 749
- 4,173
- Total Liabilities
- 8,899
- 5,107
- Capital Work in Progress
- 211
- 103
- 1,220
- 0
- Cash & Bank
- 460
- 1,799
- Total Assets
- 8,899
- Total Debt
- 4,045
- Net Working Capital
- 1,264
- Contingent Liabilities
- 473
- Book Value per Share
- 220.61
- Face Value
- 1.00
- Total Debt
- 4,045
- Net Working Capital
- 1,264
- Contingent Liabilities
- 473
- Book Value per Share
- 220.61
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 16
- 4,071
- 421
- Trade Payables
- 1,136
- 3,814
- Total Liabilities
- 9,457
- 5,401
- Capital Work in Progress
- 300
- 124
- 1,391
- 0
- Cash & Bank
- 249
- 1,993
- Total Assets
- 9,457
- Total Debt
- 3,469
- Net Working Capital
- 1,185
- Contingent Liabilities
- 756
- Book Value per Share
- 262.33
- Face Value
- 1.00
- Total Debt
- 3,469
- Net Working Capital
- 1,185
- Contingent Liabilities
- 756
- Book Value per Share
- 262.33
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 16
- 4,793
- 598
- Trade Payables
- 1,020
- 4,892
- Total Liabilities
- 11,319
- 5,648
- Capital Work in Progress
- 492
- 115
- 1,417
- 0
- Cash & Bank
- 1,370
- 2,276
- Total Assets
- 11,319
- Total Debt
- 4,840
- Net Working Capital
- 2,495
- Contingent Liabilities
- 595
- Book Value per Share
- 301.93
- Face Value
- 1.00
- Total Debt
- 4,840
- Net Working Capital
- 2,495
- Contingent Liabilities
- 595
- Book Value per Share
- 301.93
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 16
- 5,588
- 889
- Trade Payables
- 1,090
- 4,728
- Total Liabilities
- 12,310
- 6,340
- Capital Work in Progress
- 264
- 69
- 1,845
- 0
- Cash & Bank
- 1,400
- 2,392
- Total Assets
- 12,310
- Total Debt
- 4,628
- Net Working Capital
- 2,419
- Contingent Liabilities
- 702
- Book Value per Share
- 351.83
- Face Value
- 1.00
- Total Debt
- 4,628
- Net Working Capital
- 2,419
- Contingent Liabilities
- 702
- Book Value per Share
- 351.83
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 16
- 4,725
- 20
- Trade Payables
- 520
- 3,482
- Total Liabilities
- 8,763
- 4,609
- Capital Work in Progress
- 278
- 241
- 1,129
- 0
- Cash & Bank
- 671
- 1,835
- Total Assets
- 8,763
- Total Debt
- 2,584
- Net Working Capital
- 1,904
- Contingent Liabilities
- 422
- Book Value per Share
- 297.84
- Face Value
- 1.00
- Total Debt
- 2,584
- Net Working Capital
- 1,904
- Contingent Liabilities
- 422
- Book Value per Share
- 297.84
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 16
- 5,299
- 463
- Trade Payables
- 568
- 3,484
- Total Liabilities
- 9,830
- 4,871
- Capital Work in Progress
- 292
- 239
- 1,255
- 0
- Cash & Bank
- 984
- 2,189
- Total Assets
- 9,830
- Total Debt
- 2,928
- Net Working Capital
- 1,918
- Contingent Liabilities
- 420
- Book Value per Share
- 333.91
- Face Value
- 1.00
- Total Debt
- 2,928
- Net Working Capital
- 1,918
- Contingent Liabilities
- 420
- Book Value per Share
- 333.91
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 16
- 5,377
- 258
- Trade Payables
- 821
- 4,457
- Total Liabilities
- 10,929
- 5,183
- Capital Work in Progress
- 773
- 256
- 1,380
- 0
- Cash & Bank
- 1,014
- 2,321
- Total Assets
- 10,929
- Total Debt
- 3,410
- Net Working Capital
- 1,990
- Contingent Liabilities
- 402
- Book Value per Share
- 339.19
- Face Value
- 1.00
- Total Debt
- 3,410
- Net Working Capital
- 1,990
- Contingent Liabilities
- 402
- Book Value per Share
- 339.19
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 16
- 5,404
- 196
- Trade Payables
- 856
- 4,844
- Total Liabilities
- 11,316
- 5,091
- Capital Work in Progress
- 1,252
- 42
- 1,290
- 916
- Cash & Bank
- 957
- 1,768
- Total Assets
- 11,316
- Total Debt
- 3,414
- Net Working Capital
- 1,743
- Contingent Liabilities
- 456
- Book Value per Share
- 343.00
- Face Value
- 1.00
- Total Debt
- 3,414
- Net Working Capital
- 1,743
- Contingent Liabilities
- 456
- Book Value per Share
- 343.00
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 16
- 6,224
- 219
- Trade Payables
- 1,005
- 5,035
- Total Liabilities
- 12,499
- 5,176
- Capital Work in Progress
- 2,715
- 44
- 1,129
- 892
- Cash & Bank
- 1,089
- 1,456
- Total Assets
- 12,499
- Total Debt
- 2,437
- Net Working Capital
- 1,345
- Contingent Liabilities
- 368
- Book Value per Share
- 394.94
- Face Value
- 1.00
- Total Debt
- 2,437
- Net Working Capital
- 1,345
- Contingent Liabilities
- 368
- Book Value per Share
- 394.94
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 16
- 7,058
- 162
- Trade Payables
- 1,234
- 6,795
- Total Liabilities
- 15,266
- 6,966
- Capital Work in Progress
- 2,962
- 61
- 1,232
- 1,070
- Cash & Bank
- 1,268
- 1,708
- Total Assets
- 15,266
- Total Debt
- 3,220
- Net Working Capital
- 1,570
- Contingent Liabilities
- 419
- Book Value per Share
- 447.70
- Face Value
- 1.00
- Total Debt
- 3,220
- Net Working Capital
- 1,570
- Contingent Liabilities
- 419
- Book Value per Share
- 447.70
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,268 | 1,303 | 1,122 | 1,543 | 1,784 | 838 | 661 | 971 | 1,072 | 1,227 | |
| Cash from Investing | -450 | -618 | -1,012 | -327 | -739 | -380 | -544 | -608 | 488 | -1,260 |
| Cash from Financing | -686 | -901 | 657 | -1,050 | -1,709 | -33 | -157 | -432 | -1,453 | 95 |
| 132 | -216 | 767 | 166 | -664 | 425 | -40 | -69 | 107 | 62 | |
| Free Cash Flow | 923 | 597 | 313 | 635 | 1,784 | 154 | -430 | -9 | -344 | -1,364 |
| OCF / Net Profit | 2.21 | 2.05 | 1.94 | 2.28 | 3.11 | 2.03 | -10.18 | 13.36 | 1.28 | 3.09 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 4,253 | 3,484 | 2,457 | 2,135 | 1,156 | -1,993 |
| OCF / Net Profit | 2.21 | 2.05 | 1.94 | 2.28 | 3.11 | 2.03 | -10.18 | 13.36 | 1.28 | 3.09 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 4,253 | 3,484 | 2,457 | 2,135 | 1,156 | -1,993 |
Mar 2017
- 1,268
- Cash from Investing
- -450
- Cash from Financing
- -686
- 132
- Free Cash Flow
- 923
- OCF / Net Profit
- 2.21
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.21
- Cumulative 5-Year FCF
- 0
Mar 2018
- 1,303
- Cash from Investing
- -618
- Cash from Financing
- -901
- -216
- Free Cash Flow
- 597
- OCF / Net Profit
- 2.05
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.05
- Cumulative 5-Year FCF
- 0
Mar 2019
- 1,122
- Cash from Investing
- -1,012
- Cash from Financing
- 657
- 767
- Free Cash Flow
- 313
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- 0
Mar 2020
- 1,543
- Cash from Investing
- -327
- Cash from Financing
- -1,050
- 166
- Free Cash Flow
- 635
- OCF / Net Profit
- 2.28
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.28
- Cumulative 5-Year FCF
- 0
Mar 2021
- 1,784
- Cash from Investing
- -739
- Cash from Financing
- -1,709
- -664
- Free Cash Flow
- 1,784
- OCF / Net Profit
- 3.11
- Cumulative 5-Year FCF
- 4,253
- OCF / Net Profit
- 3.11
- Cumulative 5-Year FCF
- 4,253
Mar 2022
- 838
- Cash from Investing
- -380
- Cash from Financing
- -33
- 425
- Free Cash Flow
- 154
- OCF / Net Profit
- 2.03
- Cumulative 5-Year FCF
- 3,484
- OCF / Net Profit
- 2.03
- Cumulative 5-Year FCF
- 3,484
Mar 2023
- 661
- Cash from Investing
- -544
- Cash from Financing
- -157
- -40
- Free Cash Flow
- -430
- OCF / Net Profit
- -10.18
- Cumulative 5-Year FCF
- 2,457
- OCF / Net Profit
- -10.18
- Cumulative 5-Year FCF
- 2,457
Mar 2024
- 971
- Cash from Investing
- -608
- Cash from Financing
- -432
- -69
- Free Cash Flow
- -9
- OCF / Net Profit
- 13.36
- Cumulative 5-Year FCF
- 2,135
- OCF / Net Profit
- 13.36
- Cumulative 5-Year FCF
- 2,135
Mar 2025
- 1,072
- Cash from Investing
- 488
- Cash from Financing
- -1,453
- 107
- Free Cash Flow
- -344
- OCF / Net Profit
- 1.28
- Cumulative 5-Year FCF
- 1,156
- OCF / Net Profit
- 1.28
- Cumulative 5-Year FCF
- 1,156
Mar 2026
- 1,227
- Cash from Investing
- -1,260
- Cash from Financing
- 95
- 62
- Free Cash Flow
- -1,364
- OCF / Net Profit
- 3.09
- Cumulative 5-Year FCF
- -1,993
- OCF / Net Profit
- 3.09
- Cumulative 5-Year FCF
- -1,993
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 36.96 | 41.27 | 36.07 | 56.39 | 52.51 | 26.01 | -3.84 | 4.88 | 53.13 | 25.22 |
| Book Value (₹) | 220.61 | 262.33 | 301.93 | 351.83 | 297.84 | 333.91 | 339.19 | 343.00 | 394.94 | 447.70 |
| Dividend per Share (₹) | 3.00 | 3.00 | 4.50 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Cash EPS (₹) | 55.61 | 67.37 | 59.52 | 63.89 | 57.98 | 49.93 | 30.76 | 28.77 | 76.26 | 53.03 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 22.81% | 20.62% | 19.48% | 26.53% | 23.19% | 19.05% | 12.97% | 13.44% | 15.35% | 14.41% |
| Net Margin % | 9.57% | 8.39% | 6.33% | 11.34% | 9.41% | 6.74% | -1.03% | 1.08% | 10.94% | 4.55% |
| ROE % | 17.96% | 16.87% | 12.97% | 13.02% | 11.09% | 8.21% | -1.21% | 1.34% | 14.35% | 5.97% |
| ROCE % | 14.44% | 15.21% | 13.06% | 12.20% | 12.02% | 9.97% | 2.53% | 5.02% | 13.92% | 8.69% |
| 6.52% | 6.91% | 5.55% | 5.74% | 5.45% | 4.44% | -0.63% | 0.65% | 7.02% | 2.86% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 59 | 52 | 48 | 78 | 63 | 52 | 55 | 51 | 43 | 41 |
| Inventory Days | 74 | 63 | 56 | 100 | 89 | 71 | 77 | 73 | 58 | 49 |
| Payable Days | 124 | 120 | 112 | 265 | 191 | 133 | 135 | 143 | 147 | 155 |
| 9 | -6 | -7 | -87 | -39 | -10 | -4 | -19 | -46 | -64 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 1.18x | 0.85x | 1.01x | 0.83x | 0.55x | 0.55x | 0.63x | 0.63x | 0.39x | 0.46x |
| Interest Coverage (x) | 3.16x | 4.02x | 5.11x | 6.07x | 5.73x | 5.33x | 1.15x | 1.63x | 5.08x | 3.90x |
| 1.75x | 1.59x | 2.19x | 1.92x | 2.82x | 2.20x | 2.12x | 1.92x | 1.62x | 1.62x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 1.95% | 28.26% | 21.19% | -34.41% | 2.05% | 0.52% | 2.47% | 6.71% | 7.93% | 14.45% |
| Operating Profit Growth % | 8.71% | 13.74% | 13.88% | -10.67% | -10.80% | -17.43% | -30.24% | 19.03% | 26.92% | 7.74% |
| Net Profit Growth % | 48.55% | 10.41% | -9.05% | 17.46% | -15.33% | -28.03% | -115.71% | 212.02% | 1050.34% | -52.47% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 227.19% | 988.73% | -52.53% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 116.50x | 16.80x | 32.37x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.66x | 2.26x | 1.82x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.88% | 0.56% | 0.61% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 11.80x | 12.56x | 11.20x |
Mar 2017
- EPS (₹)
- 36.96
- Book Value (₹)
- 220.61
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 55.61
- Operating Margin %
- 22.81%
- Net Margin %
- 9.57%
- ROE %
- 17.96%
- ROCE %
- 14.44%
- 6.52%
- Debtor Days
- 59
- Inventory Days
- 74
- Payable Days
- 124
- 9
- Debt to Equity (x)
- 1.18x
- Interest Coverage (x)
- 3.16x
- 1.75x
- Revenue Growth %
- 1.95%
- Operating Profit Growth %
- 8.71%
- Net Profit Growth %
- 48.55%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 41.27
- Book Value (₹)
- 262.33
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 67.37
- Operating Margin %
- 20.62%
- Net Margin %
- 8.39%
- ROE %
- 16.87%
- ROCE %
- 15.21%
- 6.91%
- Debtor Days
- 52
- Inventory Days
- 63
- Payable Days
- 120
- -6
- Debt to Equity (x)
- 0.85x
- Interest Coverage (x)
- 4.02x
- 1.59x
- Revenue Growth %
- 28.26%
- Operating Profit Growth %
- 13.74%
- Net Profit Growth %
- 10.41%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 36.07
- Book Value (₹)
- 301.93
- Dividend per Share (₹)
- 4.50
- Cash EPS (₹)
- 59.52
- Operating Margin %
- 19.48%
- Net Margin %
- 6.33%
- ROE %
- 12.97%
- ROCE %
- 13.06%
- 5.55%
- Debtor Days
- 48
- Inventory Days
- 56
- Payable Days
- 112
- -7
- Debt to Equity (x)
- 1.01x
- Interest Coverage (x)
- 5.11x
- 2.19x
- Revenue Growth %
- 21.19%
- Operating Profit Growth %
- 13.88%
- Net Profit Growth %
- -9.05%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 56.39
- Book Value (₹)
- 351.83
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 63.89
- Operating Margin %
- 26.53%
- Net Margin %
- 11.34%
- ROE %
- 13.02%
- ROCE %
- 12.20%
- 5.74%
- Debtor Days
- 78
- Inventory Days
- 100
- Payable Days
- 265
- -87
- Debt to Equity (x)
- 0.83x
- Interest Coverage (x)
- 6.07x
- 1.92x
- Revenue Growth %
- -34.41%
- Operating Profit Growth %
- -10.67%
- Net Profit Growth %
- 17.46%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 52.51
- Book Value (₹)
- 297.84
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 57.98
- Operating Margin %
- 23.19%
- Net Margin %
- 9.41%
- ROE %
- 11.09%
- ROCE %
- 12.02%
- 5.45%
- Debtor Days
- 63
- Inventory Days
- 89
- Payable Days
- 191
- -39
- Debt to Equity (x)
- 0.55x
- Interest Coverage (x)
- 5.73x
- 2.82x
- Revenue Growth %
- 2.05%
- Operating Profit Growth %
- -10.80%
- Net Profit Growth %
- -15.33%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 26.01
- Book Value (₹)
- 333.91
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 49.93
- Operating Margin %
- 19.05%
- Net Margin %
- 6.74%
- ROE %
- 8.21%
- ROCE %
- 9.97%
- 4.44%
- Debtor Days
- 52
- Inventory Days
- 71
- Payable Days
- 133
- -10
- Debt to Equity (x)
- 0.55x
- Interest Coverage (x)
- 5.33x
- 2.20x
- Revenue Growth %
- 0.52%
- Operating Profit Growth %
- -17.43%
- Net Profit Growth %
- -28.03%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -3.84
- Book Value (₹)
- 339.19
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 30.76
- Operating Margin %
- 12.97%
- Net Margin %
- -1.03%
- ROE %
- -1.21%
- ROCE %
- 2.53%
- -0.63%
- Debtor Days
- 55
- Inventory Days
- 77
- Payable Days
- 135
- -4
- Debt to Equity (x)
- 0.63x
- Interest Coverage (x)
- 1.15x
- 2.12x
- Revenue Growth %
- 2.47%
- Operating Profit Growth %
- -30.24%
- Net Profit Growth %
- -115.71%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 4.88
- Book Value (₹)
- 343.00
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 28.77
- Operating Margin %
- 13.44%
- Net Margin %
- 1.08%
- ROE %
- 1.34%
- ROCE %
- 5.02%
- 0.65%
- Debtor Days
- 51
- Inventory Days
- 73
- Payable Days
- 143
- -19
- Debt to Equity (x)
- 0.63x
- Interest Coverage (x)
- 1.63x
- 1.92x
- Revenue Growth %
- 6.71%
- Operating Profit Growth %
- 19.03%
- Net Profit Growth %
- 212.02%
- 227.19%
- P/E (x)
- 116.50x
- P/B (x)
- 1.66x
- Dividend Yield %
- 0.88%
- 11.80x
Mar 2025
- EPS (₹)
- 53.13
- Book Value (₹)
- 394.94
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 76.26
- Operating Margin %
- 15.35%
- Net Margin %
- 10.94%
- ROE %
- 14.35%
- ROCE %
- 13.92%
- 7.02%
- Debtor Days
- 43
- Inventory Days
- 58
- Payable Days
- 147
- -46
- Debt to Equity (x)
- 0.39x
- Interest Coverage (x)
- 5.08x
- 1.62x
- Revenue Growth %
- 7.93%
- Operating Profit Growth %
- 26.92%
- Net Profit Growth %
- 1050.34%
- 988.73%
- P/E (x)
- 16.80x
- P/B (x)
- 2.26x
- Dividend Yield %
- 0.56%
- 12.56x
Mar 2026
- EPS (₹)
- 25.22
- Book Value (₹)
- 447.70
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 53.03
- Operating Margin %
- 14.41%
- Net Margin %
- 4.55%
- ROE %
- 5.97%
- ROCE %
- 8.69%
- 2.86%
- Debtor Days
- 41
- Inventory Days
- 49
- Payable Days
- 155
- -64
- Debt to Equity (x)
- 0.46x
- Interest Coverage (x)
- 3.90x
- 1.62x
- Revenue Growth %
- 14.45%
- Operating Profit Growth %
- 7.74%
- Net Profit Growth %
- -52.47%
- -52.53%
- P/E (x)
- 32.37x
- P/B (x)
- 1.82x
- Dividend Yield %
- 0.61%
- 11.20x
Documents
Announcements
- Shareholders meeting
2026-08-17 - Jubilant Pharmova Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
- Copy of Newspaper Publication
2026-08-11 - Jubilant Pharmova Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
May 2026
Feb 2026
Oct 2025